CliffBio
small molecule

DICLEGIS

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyDuchesnay Usa →See this company's full patent-cliff portfolio

Drug detail

Brand nameDICLEGIS
Active ingredientDOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Strength10MG;10MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2013
Marketing statusRX

More from Duchesnay Usa

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DICLEGIS patent cliff — loss of exclusivity — | CliffBio